Has surpassed $200,000 in total revenue! The product has reached 121% of the May sales target. Production of the third batch has been launched.
Has surpassed $60,000 in total revenue! The product has achieved 162% of the May sales target.
Has surpassed $13,000 in total revenue, with 777 units sold! The product has reached 156% of the May sales target.
Has surpassed $10,000 in total revenue! The product has achieved 411% of the May sales target.
Has surpassed $9,000 in total revenue, with over 600 units sold! The product has reached 322% of the May sales target.
Has surpassed $4,000 in total revenue! The product has achieved 586% of the May sales target.
The product has received its first sales! Rating: 4.7.
The product was added to the HSA/FSA program, which means it can now be purchased using an FSA or HSA medical account.
Part of the batch has been shipped to the prep center in the US. Air shipment from Korea to Amazon is expected this week.
Part of the batch was shipped to Amazon via air delivery. Arrival is expected by the end of May.
Received CA Prop 65 certification, allowing the product to be sold in California.
Completed a hypoallergenic test of the formula. Dermatological testing has been launched.
Production of the second batch has been paid for, and the factory has started production.